Top Rated Articles

Wedding Invitations Don'ts

By Sarrah Beaumont | 5 Rating | Published 2009-07-21 18:24:23

Much is already written regarding weddin...
Read more..

Car Bodywork Paint Repair Restoration Techniques - Spray Painting

By Mario Goldstein | 5 Rating | Published 2009-07-22 21:11:32

When buying a car one of the biggest cho...
Read more..

How Do I Make My Home Insurance Company Hurry Up?

By Anthony Peck | 5 Rating | Published 2009-08-07 05:45:36

Is there anything more frustrating that ...
Read more..

Do You Really Need Car Insurance

By Warren Fets | 5 Rating | Published 2009-08-21 03:45:27

There are many advantages to having car ...
Read more..

So What Do You Really Know About Fashion?

By Benedict Smythe | 5 Rating | Published 2009-08-24 15:48:39

Fashion is extremely seductive, slightly...
Read more..

How Top Companies Expanding Their Presence in Interventional Oncology By Dheeraj Shaha

  in Business | Published 2019-05-15 12:36:50 | 12 Reads | Unrated

Summary

The global interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%

Full Content

According to the new market research report "Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024", published by MarketsandMarkets™, the Interventional Oncology Market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%.

Rising preference for minimally invasive procedures, incr

easing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research are some of the major factors driving the growth of this market.

Don't miss out on business opportunities in Interventional Oncology Market

Request FREE Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203687164

The TARE/SIRT segment accounted for the largest share of the Interventional Oncology Market, by procedure, in 2018

Based on procedure, the Interventional Oncology Market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. In 2018, the TARE/SIRT procedures segment accounted for the largest market share majorly due to the rising prevalence of cancer, increasing demand for minimally invasive procedures, growing adoption of embolization procedures, and the clinical efficacy of Yttrium-90 radioembolic agents (which are used in these procedures).

Browse and in-depth TOC on "Interventional Oncology Market"

140 – Tables
33 – Figures
180 – Pages  

Liver cancer segment to register the highest CAGR in the Interventional Oncology Market, by application, during the forecast period


Based on cancer type, the Interventional Oncology Market is segmented into liver cancer, kidney cancer, lung cancer, bone cancer, and other cancers (includes pediatric cancer, prostate cancer, and breast cancer). Growth in this segment can be attributed to factors such as rising cases of liver cancer across the globe and growing initiatives/research activities for developing advanced liver cancer therapies using interventional oncology.

Download an Illustrative overview of the report:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164

North America accounted for the largest share of the Interventional Oncology Market in 2018

The Interventional Oncology Market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Interventional Oncology Market owing to factors such as the rising incidence of cancer, easy accessibility to interventional oncology, and the high adoption of technological advancements (owing to the significant per capita annual healthcare expenditure by the US government).

The major players operating in the Interventional Oncology Market are Medtronic (Ireland), Boston Scientific (US), BTG plc (UK), Merit Medical Systems (US), and Terumo (Japan). The other prominent players operating in the overall Interventional Oncology Market include AngioDynamics (US), Ethicon (part of J&J) (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves Medical (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), and Interface Biomaterials BV (Netherlands).

Comments

Bio Synthesis :Life Science Services at Custom DNA Synthesis
DNA Synthesis
Custom RNA Synthesis
RNA Synthesis
Custom Oligo Synthesis
Cell line authentication
Solid Phase Peptide Synthesis
Cell Line Identification
stapled peptides
Bioconjugation
rna oligo synthesis
long dna synthesis
Amino Acid Analysis
Custom Oligos
Custom Oligo
Oligonucleotide Synthesis
cell line genotyping
facebook.com/BioSynthesisInc/
twitter.com/biosyntwit
linkedin.com/company/bio-synthesis-inc./

Login to comment

About the Author

About OpenArticle

openarticles.com is an article website dealing with the collection of quality articles on a number of subjects including entertainment, arts and science, medicine, career, classifieds, computers, technology, culture, education, entertainment, health, wellness, fitness, diet, writing, world affairs and many more. Read more...

Follow On

Contact: Contact OpenArticles